高压液相色谱纯化肾综合征出血热病毒血凝素及其性状分析

用吐温８０－乙醚（ＴＥ）法、蔗糖－丙酮（ＳＡ）法、丙酮－乙醚（ＡＥ）法分别从肾综合征出血热病毒（ＨＦＲＳＶ）感染的Ｖｅｒｏ－Ｅ６细胞培养和乳小白鼠脑组织中制备病毒血凝素（ＨＡＮ），定量对比证明其制备效果，结果无明显差异。粗制ＨＡＮ经高压液相色谱（ＥＰＬＣ）纯化，有４个洗脱峰，血凝活性物质存在于峰１。纯化ＨＡＮ在ＳＤＳ－ＰＡＧＥ中呈单一区带，分子量５６．６ＫＤ，ＨＡＮ相对含量７９．６％。纯化ＨＡＮ在蔗糖密度梯度液中有一条１．１５～１．１６ｇ／ｃｍ３的沉淀，粗制ＨＡＮ有３条沉淀。电镜观察纯化ＨＡＮ中为大小相等的球状颗粒。粗制ＨＡＮ的高密度沉淀中可见到病样颗粒。对几种常用消毒剂、氧化剂、去垢剂对ＨＡＮ的灭活作用做了实验对比观察。     

PHA RMA COKINETICS OF CUPRIC－BIS（SALICYLALDEHYDE－2－FURA NTHIOCA RBOXY－HYDRAZONATE） DICHLORIDE（CSFTCH） IN RABBITS

ＰＨＡＲＭＡＣＯＫＩＮＥＴＩＣＳＯＦＣＵＰＲＩＣ－ＢＩＳ（ＳＡＬＩＣＹＬＡＬＤＥＨＹＤＥ－２－ＦＵＲＡＮＴＨＩＯＣＡＲＢＯＸＹ－ＨＹＤＲＡＺＯＮＡＴＥ）ＤＩＣＨＬＯＲＩＤＥ（ＣＳＦＴＣＨ）ＩＮＲＡＢＢＩＴＳ￥ＧａｏＹｕｎｓｈｅｎｇ；ＺｈｕＹｕｙｕｎ（...     

An alkylpolyglucoside surfactant as a prospective pharmaceutical excipient for topical formulations: The influence of oil polarity on the colloidal structure and hydrocortisone in vitro/in vivo permeation

There is a growing need for research into new skin- and environment-friendly surfactants. This paper focuses on a natural surfactant of an alkylpolyglucoside type, which can form both thermotropic and lyotropic liquid-crystalline phases. The aim of this study was to relate some physicochemical properties (characterised by polarisation and transmission electron microscopy, thermal analysis and rheology) of the three formulations based on cetearyl glucoside and cetearyl alcohol, to the results of in vitro and in vivo bioavailability of hydrocortisone (HC). The three formulations contained oils of different polarity (medium chain triglycerides: MG, isopropyl myristate: IPM and light liquid paraffin: LP), respectively. In vitro permeation was followed through the artificial skin constructs (ASC), while the parameters measured in vivo were erythema index: EI (using instrumental human skin blanching assay), transepidermal water loss (TEWL) and stratum corneum hydration (SCH). The vehicles based on cetearyl glucoside and cetearyl alcohol showed a complex colloidal structure of lamellar liquid-crystalline and lamellar gel-crystalline type, depending on oil polarity. Rheological profile of the vehicle was directly related to the in vitro profile of the HC permeation. In vivo results suggested that the vehicle with MG retarded the HC permeation, whereas less polar IPM and non-polar LP enhanced it. It is suggested that the enhancement is achieved either by a direct interaction with lipid lamellae of the SC or indirectly by improving skin hydration.

There were no adverse effects during in vivo study, which indicates a good safety profile of this alkylpolyglucoside surfactant.     

高效液相色谱法检测血中表阿霉素的研究

用ＺｏｒｂａｘＣ－８柱成功地分离了阿霉素、表阿霉素及其代谢产物。在此基础上建立了用阿霉素作内标物定量测定表阿霉素的分析方法，其最低检测限为２ｎｇ／ｍｌ，线性范围１０－３００ｎｇ／ｍｌ。     

高效液相色谱法测定硫酸奈替米星注射液的含量

目的采用高效液相色谱法测定硫酸奈替米星及注射液的含量。方法以μ-Diamonsil—C18为分析柱，流动相为1．5％的磷酸二氢钾-乙睛，流速为1．0ml／min，检测渡长为205nm。含量测定用峰面积外标法。结果硫酸奈替米星在0．1—1．6mg／ml浓度范围内呈现良好线性关系，r=0．9998．平均回收率为99．5％，RSD=0．4％（n=9）。结论本方法操作简便、快速，结果准确可靠，重现性好，均能很好地满足质量控制的要求，为开辟氨基糖苷类抗生素含量测定的仪器提供了一定借鉴。     

盐酸齐拉西酮在中国健康志愿者中的药代动力学研究

目的评价国产盐酸齐拉西酮胶囊的人体药代动力学特点;初步评价国产盐酸齐拉西酮胶囊的安全性。方法采用HPLC法测定血浆中齐拉西酮浓度。10位男性健康受试者进食时单剂量口服40mg盐酸齐拉西酮胶囊。于服药前及服药后0.5、1、2、3、4、5、6、8、10、12、24、36、48小时采集5m l血样。抗凝处理取血浆,-20℃保存,用于血药浓度的测定。安全性评价包括体检、实验室检查(心电图、血常规、生化常规及尿常规等)及不良事件的记录。结果主要药动学参数:Cm ax为(175.0±63.73)ng/m l;Tm ax为(3.80±1.32)h;MRT为(9.37±1.53)h;t1/2为(6.10±1.65)h;Ka为0.1831±0.0708/h;Kel为0.1219±0.0349/h;Vd为(685.3±325.4)L;C l为(83.30±34.50)L/h;AUC0→t为(1312±261.3)ng/m l/h,AUC0→∝为(1339±261.1)ng/m l/h。药物不良事件主要为嗜睡、口干、头昏、静坐不能、体位性低血压等,程度多为轻至中度,均能在短时间内缓解。结论研究结果显示了国产盐酸齐拉西酮在中国人中药代动力学特点,单剂量口服胶囊40mg是安全的。     

Impaired early bone formation in periodontal fenestration defects in dogs following application of insulin-like growth factor (II). Basic fibroblast growth factor and transforming growth factor beta 1

Abstract. Effects of a topically applied growth factor combination on fibroblast migration, collagen fiber formation and bone regeneration were studied in standardized periodontal defects in 4 beagle dogs. Following elevation of facial mucoperiosteal flaps, fenestration defects, 3 mm in diameter, were made through the cortical bone and into the dentin of maxillary and mandibular teeth. Collagen sponges, impregnated with 200 ng insulin-like growth factor II, 20 ng basic fibroblast growth factor and 6 ng transforming growth factor beta 1 were fitted to defects randomly in right or left quadrants and the flaps repositioned and sutured. Contralateral control defects received the collagen with vehicle only. Experimental procedures were staggered to allow observations of healing 3, 7, 10, and 14 days after surgery. Histometric analysis showed no differences in fibroblast and collagen density between control and growth factor defects. Bone regeneration was significantly greater in control than in growth factor defects 10 and 14 days after surgery. The rate of healing generally appeared more affected by intra-dog variations or procedural variations than by the growth factor combination.     

岛状皮瓣转移修复小腿及足部骨外露创面

自1986年1月以来,我们使用5种岛状皮瓣为5例小腿及足部骨外露病人修复了创面,效果满意。笔者认为:岛状皮瓣转移术具有手术操作简单,安全可靠,血供丰富,抗感染能力强,术后处理容易等优点。本文还详细介绍了全部病例及手术注意事项。     

液相色谱测定隐形眼镜保护药水中EDTA二钠和山梨酸钾的含量

采用反相高效液相色谱法,以0.02mol/L硼砂为流动相,YNG C_(16)H_(37),为固定相,检测波长288nm,测定隐形眼镜保护药水中EDTA二钠和山梨酸钾的含量。简便快速,结果准确可靠。回收率100.26％(EDTA)、100.36％(山梨酸钾)。相对标准偏差0.85％(EDTA)、0.41％(山梨酸钾)。     

Accelerating effects of epidermal growth factor on skin lesions of pemphigus vulgaris: a double-blind, randomized, controlled trial

BACKGROUND: Pemphigus vulgaris (PV) is a severe blistering disease involving the skin and mucous membranes. The most common causes of death in these patients are adverse effects of drugs, and infection. Skin lesions are one of the important sources of infection. Thus, any local treatment that could reduce healing time of lesions and consequently reduce the total dosage of drugs needed to treat is favourable. OBJECTIVE: To evaluate the efficacy of epidermal growth factor (EGF) in reducing healing time of lesions in patients with pemphigus vulgaris. METHODS: In this randomized, double-blind, within-patient, left/right, controlled trial, 20 hospitalized patients with pathologial and immunohistologial (direct and indirect immunoflourecence) proven pemphigus vulgaris (PV) were chosen. In addition, all patients had at least one appropriate pemphigus lesion on each side of the body that had not healed after 2-week systemic therapy and sterile saline washing. EGF (10 microg/g) in 0.1% silver sulfadiazine cream vs. 0.1% silver sulfadiazine cream alone was applied randomly on one side of the body. RESULTS: Kaplan-Meier survival analysis suggested that median time to heal with application of EGF plus silver sulfadiazine cream was 9 days, in comparison with 15 days for silver sulfadiazine cream alone (log-rank test, P=0.0003). No intervention-related adverse effect was observed during the study. CONCLUSIONS: EGF can significantly reduce healing time of skin lesions in patients with pemphigus vulgaris, at least when this cream base is applied (Cochrane skin group identifier: CSG20).